About the Sinovac, Sputnik V and Johnson & Johnson Covid-19 vaccines


An inactivated adenovirus is used as the vector to deliver the gene for the SARS-CoV-2 spike protein into the body in the Sinovac, Sputnik V, and Johnson and Johnson Covid-19 vaccines. — Wikimedia Commons

The efficacy of the Sinovac vaccine (officially named CoronaVac, but more popularly known by the name of its developer Beijing-based biopharmaceutical company Sinovac Biotech Limited) has been found to be to be 50.4% in preventing symptomatic Covid-19 by researchers in Brazil.

The director of the Chinese Center for Disease Control and Prevention himself has said that “Chinese vaccines don’t have very high protection rates”, and that the Chinese government is considering mixing the vaccines to give their efficacy a boost.

Unlock 30% Savings on Ad-Free Access Now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Stop eating ultraprocessed food if you don't want an early death
How can you tell if you're dehydrated?
Toxic pesticide found in tampons, say British NGOs
Time does not always heal major trauma
This group of people needs screening for skin cancer
These issues from Covid-19 remain unanswered
Can't hear well but still want to be sociable?
Puberty occurring at an unusually early age
Shining light to kill cancer cells
Tips on jogging for seniors

Others Also Read